9780822348238

The Professional Guinea Pig: Big Pharma and the Risky World of Human Subjects

by
  • ISBN13:

    9780822348238

  • ISBN10:

    0822348233

  • Edition: 1st
  • Format: Paperback
  • Copyright: 2010-07-01
  • Publisher: DUKE UNIVERSITY PRESS
  • Purchase Benefits
  • Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
  • We Buy This Book Back!
    In-Store Credit: $2.10
    Check/Direct Deposit: $2.00
List Price: $23.95 Save up to $0.72
  • Buy New
    $23.23

    USUALLY SHIPS IN 7-10 BUSINESS DAYS

Supplemental Materials

What is included with this book?

  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

Summary

The Professional Guinea Pigdocuments the emergence of the professional research subject in Phase I clinical trials testing the safety of drugs in development. Until the mid-1970s, Phase I trials were conducted on prisoners. After that practice was outlawed, the pharmaceutical industry needed a replacement population and began to aggressively recruit healthy, paid subjects, some of whom came to depend on the income, earning their living by continuously taking part in these trials. Drawing on ethnographic research among self-identified "professional guinea pigs" in Philadelphia, Roberto Abadie examines their experiences and views on the conduct of the trials and the risks they assume by participating. Some of the research subjects he met had taken part in more than 80 Phase I trials. While Abadie found that the professional guinea pigs tended to believe that most clinical trials pose only a moderate health risk, he contends that the hazards presented by continuous participation, such as exposure to potentially dangerous drug interactions, are discounted or ignored by research subjects in need of money. The risks to professional guinea pigs are disregarded by the pharmaceutical industry, because it has become dependent on the routine participation of experienced research subjects. Arguing that financial incentives compromise the ethical imperative for informed consent to be freely given by clinical-trials subjects, Abadie confirms the need to reform policies regulating the participation of paid subjects in Phase I clinical trials.

Author Biography

Roberto Abadie is a Visiting Scholar with the Health Sciences Doctoral Programs at the Graduate Center, City University of New York.

Table of Contents

A Note on Methodp. ix
Acknowledgmentsp. xi
Introduction: A Guinea Pig's Wage: Risk, Body Commodification, and the Ethics of Pharmaceutical Research in Americap. 1
Guinea-Pigging: The In/Formal Economy of Phase I Clinical Trials in Philadelphiap. 21
Market Recruitment, Identity, and Resistance among Professional Guinea Pigsp. 45
Local Knowledge and Risk Management among Professional Guinea Pigsp. 65
Big Pharma and HIV Clinical Trials: A Case Studyp. 85
Strategies of Survival: HIV Clinical Trials and the Fight for Their Livesp. 97
From Prisoners to Professionals: A Brief History of the Clinical-Trials Enterprisep. 121
Ethics and the Exploitation of the Poor in Clinical Trials Researchp. 137
Conclusion Living in/off the Mild Torture Economy as Trial Subjectsp. 157
Epilogue Following Up: Robert Helms, Frank Little, Dave Onion, and Spam One Last Timep. 167
Bibliographyp. 171
Indexp. 181
Table of Contents provided by Ingram. All Rights Reserved.

Rewards Program

Write a Review